Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Tel Aviv Stock Exchange
10/09/2017 10/10/2017 10/15/2017 10/16/2017 10/17/2017 Date
5660(c) 5571(c) 5308(c) 5240(c) 5184 Last
553 159 698 552 859 858 4 815 694 1 016 490 Volume
+0.50% -1.57% -4.72% -1.28% -1.07% Change
More quotes
Financials ($)
Sales 2017 22 644 M
EBIT 2017 6 282 M
Net income 2017 -
Debt 2017 34 451 M
Yield 2017 -
Sales 2018 20 624 M
EBIT 2018 5 050 M
Net income 2018 -
Debt 2018 27 776 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 2,19x
EV / Sales2018 2,08x
Capitalization 15 186 M
More Financials
Company
Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company, which provides patient-centric healthcare solutions.It operates through two segments: Generic Medicines and Specialty Medicines.The Generic Medicines segment includes chemical and therapeutic equivalents of originator medicines... 
Sector
Pharmaceuticals
Calendar
11/02 | 12:00pmEarnings Release
More about the company
Latest news on TEVA PHARMACEUTICAL INDUST
04:22p TEVA PHARMACEUTICAL INDUSTRIES LIMIT : TEVA The Law Offices of Vincent Wong Remi..
04:15p TEVA PHARMACEUTICAL INDUSTRIES : "Teva unlikely to remain priced below Mylan"
03:54p Drugmakers Amneal, Impax to combine in generics push
02:06p TEVA PHARMACEUTICAL INDUSTRIES : Announces Submission of Biologics License Appli..
10/16 TEVA PHARMACEUTICAL INDUSTRIES : "Teva unlikely to remain priced below Mylan"
10/16 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : Khang & Khang LLP Announces Securities Cl..
10/16 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : Levi & Korsinsky, LLP Reminds Shareholder..
10/14 DEADLINE ALERT : Brower Piven Reminds Shareholders of Approaching Deadline in Cl..
10/14 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : SHAREHOLDER REMINDER: Lundin Law PC Annou..
10/13 Antares Pharma Provides XYOSTED Regulatory Update
More news
Sector news : Pharmaceuticals - NEC
03:54p Drugmakers Amneal, Impax to combine in generics push
11:09aDJHUTCHISON CHINA MEDITECH : AstraZeneca Say Drug Shows Potential to Treat Lung Ca..
08:48aDJDaimler Charts Leaner Approach -- WSJ
08:46aDJASTRAZENECA : FDA Accepts Imfinzi Supplemental Biologics License Application; Gr..
06:48aDJJOHNSON & JOHNSON : Raises Guidance on Earnings Beat
More sector news : Pharmaceuticals - NEC
Latest Tweets
10/15Gofen & Glossberg LLC IL Has $2.25 Million Holdings in Teva Pharmaceutica.. 
10/15Teva Pharmaceutical Industries Limited $TEVA Stock Rating Lowered by BidaskCl.. 
10/14Teva Pharmaceutical Industries Limited downgraded by BidaskClub to strong sel.. 
10/11INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsu.. 
10/10Teva Pharmaceutical Industries : to Report Third Quarter 2017 Financial Resul.. 
More tweets
Qtime:278
News from SeekingAlpha
09:59a Teva submits U.S. marketing application for migraine med fremanezumab
10/16 TEVA'S ONGOING COMPLICATIONS : Psychology And Generic Drugs
10/16 U.S. court invalidates Allergan's Restasis patents; shares down 5%
10/16 SANOFI : Upward Trajectory In 2017
10/16 Mylan Calls Allergan's Mohawk Deal A 'Sham'
Chart TEVA PHARMACEUTICAL INDUST
Duration : Period :
Teva Pharmaceutical Indust Technical Analysis Chart | TEVA | IL0006290147 | 4-Traders
Technical analysis trends TEVA PHARMACEUTICAL INDUST
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 28,0 $
Spread / Average Target 87%
Managers
NameTitle
Kåre Schultz President & Chief Executive Officer
Sol J. Barer Chairman
Carlo de Notaristefani President & CEO-Global Operations
Michael McClellan Chief Financial Officer
Michael R. Hayden Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
TEVA PHARMACEUTICAL INDUSTRIES LIMITED-59.72%15 186
JOHNSON & JOHNSON18.42%365 346
NOVARTIS13.23%226 956
ROCHE HOLDING LTD.5.20%215 359
PFIZER11.88%214 265
MERCK AND COMPANY7.68%172 751